EFFECT OF â??SAPTAMRITA VATIâ?? AND â??VIRECHANAKARMAâ?? IN TAMAKA SHWASA WITH SPECIAL REFERENCE TO BRONCHIAL ASTHMA

Phase 2

• Conditions: Health Condition 1: J452- Mild intermittent asthma

• Registration Number: CTRI/2021/04/033056
• Lead Sponsor: ational Institute of Ayurveda Jaipur

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 24 November 2021

Recruitment & Eligibility

• Status: ot Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

1.Patients willing for trial and give consent.

2.Patients of age group 18 to 70 yrs of either sex.

3.Patients having signs and symptoms of Tamak Shwasa i.e., Shwasakrucchata, Kasa (cough), Pratishyaya (chronic rhinitis), Bhasankrucchata (difficulty in speech), Nidralpata (inadequate sleep), Ghurghuraka (audible sounds)

4.Patients fit for Virechana Karma.

5.Patients who is not taking any allopathic medication for Asthma.

6. Mild & moderate cases of Bronchial Asthma

Exclusion Criteria

1.Patients not willing for trial.

2.Age below 18 years and above 70 years of age of either sex.

3.Patients suffering from Pulmonary tuberculosis, Cardiac Asthma, Bronchogenic carcinoma, Chronic obstructive Productive disease, Pleural effusion

4.Status Asthmaticus

5.Patients suffering from serious heart diseases or any other serious health aliment.

6.Patient with rectal or vaginal prolapse

7.Pregnant and lactating women

8.Patients, who are unfit for Virechana Karma

9Patients, who is taking any allopathic medication for Asthma

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Improvement in clinical Symptoms of Tamaka ShwasaTimepoint: 30 days

Secondary Outcome Measures

Name	Time	Method
1.Changes in Asthma control questionnaire <br/ ><br> 2. Changes in Spirometry- FVC1% and PEFR <br/ ><br> 3. Changes in MRC Dyospnea Scale. <br/ ><br>Timepoint: 30 DAYS